| scholarly article | Q13442814 |
| P50 | author | Thomas Foltynie | Q58050364 |
| P2093 | author name string | Iciar Aviles-Olmos | |
| Zinovia Kefalopoulou | |||
| P2860 | cites work | Functional recovery in parkinsonian monkeys treated with GDNF | Q24312738 |
| GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 | ||
| Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 | ||
| Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls | Q24682393 | ||
| Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease | Q28187904 | ||
| Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease | Q28275257 | ||
| Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial | Q28296434 | ||
| AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial | Q28307713 | ||
| Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. | Q51180323 | ||
| Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. | Q53223116 | ||
| Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan | Q56441169 | ||
| Neuroimaging in Parkinson's disease | Q57088961 | ||
| Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients | Q71778440 | ||
| Long-duration response to levodopa | Q71980877 | ||
| Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat | Q78571001 | ||
| Electronic motor function diary for patients with Parkinson's disease: a feasibility study | Q80141092 | ||
| Parkinson's disease home diary: further validation and implications for clinical trials | Q80609871 | ||
| Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease | Q39429074 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease | Q40326219 | ||
| Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. | Q40678042 | ||
| Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease | Q40861090 | ||
| Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo | Q41512760 | ||
| Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study | Q42994792 | ||
| Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants | Q42997555 | ||
| Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. | Q43109280 | ||
| Gene therapy for dopamine replacement in Parkinson's disease | Q43109283 | ||
| Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease | Q43144355 | ||
| Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. | Q43578216 | ||
| Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. | Q44037381 | ||
| Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease | Q44095653 | ||
| Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. | Q44438604 | ||
| Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. | Q44531224 | ||
| A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease | Q44571920 | ||
| Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease | Q44653423 | ||
| Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. | Q45859568 | ||
| Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism | Q45859700 | ||
| Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease | Q46803369 | ||
| Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice | Q46815723 | ||
| Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease | Q48184014 | ||
| Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease | Q48405890 | ||
| Dyskinesias following neural transplantation in Parkinson's disease. | Q48590785 | ||
| Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. | Q48730943 | ||
| An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. | Q49021986 | ||
| ??? | Q64787865 | ||
| Intracerebral adrenal medulla grafts: a review | Q28334372 | ||
| Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model | Q28344741 | ||
| Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation | Q29615640 | ||
| Transplantation of embryonic dopamine neurons for severe Parkinson's disease | Q29617304 | ||
| Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease | Q29619506 | ||
| Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer | Q31045537 | ||
| Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). | Q33704308 | ||
| The placebo response in Parkinson's disease. Parkinson Study Group | Q33708267 | ||
| Safety and tolerability of putaminal AADC gene therapy for Parkinson disease | Q33731687 | ||
| Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial | Q33870490 | ||
| Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes | Q34160461 | ||
| A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease | Q34209755 | ||
| Pathophysiology of levodopa-induced dyskinesia: potential for new therapies | Q34325365 | ||
| Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease | Q34554465 | ||
| Results from a phase I safety trial of hAADC gene therapy for Parkinson disease | Q34656075 | ||
| Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions | Q34743030 | ||
| Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough | Q35751844 | ||
| Stem cell therapy for human neurodegenerative disorders-how to make it work | Q35844778 | ||
| Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. | Q35850739 | ||
| Cell transplantation in Parkinson's disease: how can we make it work? | Q36018833 | ||
| Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective | Q36329686 | ||
| Role of DAT-SPECT in the diagnostic work up of parkinsonism | Q36814559 | ||
| The suitability of patient-based measures in the field of Parkinson's disease: a systematic review | Q36828001 | ||
| Drug treatment of Parkinson's disease | Q36902632 | ||
| Altered vesicular dopamine storage in Parkinson's disease: a premature demise | Q37159961 | ||
| Is deep brain stimulation neuroprotective if applied early in the course of PD? | Q37204988 | ||
| Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment | Q37449905 | ||
| Neuropathology of non-motor features of Parkinson disease | Q37677151 | ||
| Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations | Q37716740 | ||
| Progress and prospects: stem cells and neurological diseases | Q37794781 | ||
| Gene therapy: a viable therapeutic strategy for Parkinson's disease? | Q37801855 | ||
| The natural history of treated Parkinson's disease in an incident, community based cohort | Q38490792 | ||
| Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease | Q39111166 | ||
| Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease | Q39116027 | ||
| Factors affecting the clinical outcome after neural transplantation in Parkinson's disease | Q39360071 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 804041 | |
| P577 | publication date | 2011-12-27 | |
| P1433 | published in | Parkinson's disease | Q27723341 |
| P1476 | title | Critical aspects of clinical trial design for novel cell and gene therapies | |
| P478 | volume | 2011 |
| Q35472697 | Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration |
| Q28264812 | Minireview: Deciphering the Cellular Functions of PELP1 |
| Q26776154 | Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease |
Search more.